(165/165 characters, including spaces): Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic/Locally Advanced Breast Cancer: PERTAIN Final Analysis
ISSN
10780432
Date Issued
2023
Author(s)
DOI
10.1158/1078-0432.CCR-22-1092